One of the major successes of decades of cancer research has been the development of drugs that specifically inactivate oncogenes, genes that function abnormally, causing cells to behave erratically, become malignant and ...
Mar 1, 2022
0
59
Preclinical models that recapitulate aspects of human airway disease are essential for the advancement of novel therapeutics and vaccines. In the current study published in the journal mBIO, researchers at Baylor College ...
Feb 15, 2022
0
131
In a groundbreaking study published today, scientists describe how Ebola virus, which can persist in certain areas of the body, can re-emerge to cause fatal disease—even long after treatment with monoclonal antibodies. ...
Feb 9, 2022
0
322
Researchers from North Carolina State University have discovered that a particular molecular signaling pathway plays an important role in producing osteoarthritis (OA) pain. Using a mouse model of painful osteoarthritis, ...
Jan 27, 2022
0
107
An international research collaboration has found the cancer immunotherapy treatment, pembrolizumab, can reverse HIV latency, the ability for the virus to 'hide' inside cells of people living with HIV on antiretroviral therapy, ...
Jan 26, 2022
0
128
An international team of scientists has determined the precise structural changes in the spike protein of the omicron variant. Their observations explain how the virus is able to evade antibodies against previous variants ...
Jan 25, 2022
0
153
Several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the omicron variant now sweeping across the United States, ...
Jan 21, 2022
2
146
Researchers at UBC's faculty of medicine have conducted the world's first molecular-level structural analysis of the Omicron variant spike protein. The findings were published today in Science.
Jan 20, 2022
1
236
The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to many countries. It is expected to become the dominant variant within a few weeks or months. Initial epidemiological ...
Jan 7, 2022
2
528
As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they've used to fight infections are unlikely ...
Dec 19, 2021
1
269
